The 2020 Cell & Gene Meeting on the Mesa will be delivered in a virtual format over the course of five days. This year’s agenda includes a mix of on-demand content that will be released each morning in addition to two live-streaming panels each day at 8am PT and 12pm PT.
Jacqueline Barry, Chief Clinical Officer
Panel: European Commercialization Challenges and Outlook
With 10 advanced therapy medicinal products (ATMPs) currently marketed in Europe and four withdrawn, the sector’s commercial landscape is at turning point in Europe. So far, healthcare systems and developers have been successful in opening the way to the cell and gene therapy revolution. Treatment centers are managing patients, payers are exploring innovative ways to cover the cost for transformative therapies, and developers are inventing new ways of doing business. The next step will be to consolidate all of these successes and make them available for a significantly larger number of patients. On this panel, European business leaders will share their expectations and discuss how they are preparing to overcome these challenges.
If you would like to request a meeting, please send your request to Nuno Madeira Do O, Senior Business Development Manager via the online partnering tool.
Full conference information and agenda available here